Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)

Peter S Sever; Neil R Poulter; Björn Dahlöf; Hans Wedel; Rory Collins; Gareth Beevers; Mark Caulfield; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)

Peter S Sever, Neil R Poulter, Björn Dahlöf, Hans Wedel, Rory Collins, Gareth Beevers, Mark Caulfield, Sverre E Kjeldsen, Arni Kristinsson, Gordon T McInnes, Jesper Mehlsen, Markku Nieminen, Eoin O'Brien, Jan Ostergren

Department of Clinical Physiology and Nuclear Medicine

358 Citations (Scopus)

Abstract

This study aims to establish the benefits of lowering cholesterol in diabetic patients with well-controlled hypertension and average/below-average cholesterol concentrations, but without established coronary disease.

Original language	English
Journal	Diabetes Care
Volume	28
Issue number	5
Pages (from-to)	1151-7
Number of pages	7
ISSN	0149-5992
Publication status	Published - 1 May 2005

Cite this

Sever, P. S., Poulter, N. R., Dahlöf, B., Wedel, H., Collins, R., Beevers, G., Caulfield, M., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., Mehlsen, J., Nieminen, M., O'Brien, E., & Ostergren, J. (2005). Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). Diabetes Care, 28(5), 1151-7.

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). / Sever, Peter S; Poulter, Neil R; Dahlöf, Björn et al.
In: Diabetes Care, Vol. 28, No. 5, 01.05.2005, p. 1151-7.

Research output: Contribution to journal › Journal article › Research › peer-review

Sever, PS, Poulter, NR, Dahlöf, B, Wedel, H, Collins, R, Beevers, G, Caulfield, M, Kjeldsen, SE, Kristinsson, A, McInnes, GT, Mehlsen, J, Nieminen, M, O'Brien, E & Ostergren, J 2005, 'Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)', Diabetes Care, vol. 28, no. 5, pp. 1151-7.

@article{b9ae42dee7a04bebbca1a3bae43688a0,

title = "Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)",

abstract = "This study aims to establish the benefits of lowering cholesterol in diabetic patients with well-controlled hypertension and average/below-average cholesterol concentrations, but without established coronary disease.",

author = "Sever, \{Peter S\} and Poulter, \{Neil R\} and Bj{\"o}rn Dahl{\"o}f and Hans Wedel and Rory Collins and Gareth Beevers and Mark Caulfield and Kjeldsen, \{Sverre E\} and Arni Kristinsson and McInnes, \{Gordon T\} and Jesper Mehlsen and Markku Nieminen and Eoin O'Brien and Jan Ostergren",

year = "2005",

month = may,

day = "1",

language = "English",

volume = "28",

pages = "1151--7",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association",

number = "5",

}

TY - JOUR

T1 - Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)

AU - Sever, Peter S

AU - Poulter, Neil R

AU - Dahlöf, Björn

AU - Wedel, Hans

AU - Collins, Rory

AU - Beevers, Gareth

AU - Caulfield, Mark

AU - Kjeldsen, Sverre E

AU - Kristinsson, Arni

AU - McInnes, Gordon T

AU - Mehlsen, Jesper

AU - Nieminen, Markku

AU - O'Brien, Eoin

AU - Ostergren, Jan

PY - 2005/5/1

Y1 - 2005/5/1

N2 - This study aims to establish the benefits of lowering cholesterol in diabetic patients with well-controlled hypertension and average/below-average cholesterol concentrations, but without established coronary disease.

AB - This study aims to establish the benefits of lowering cholesterol in diabetic patients with well-controlled hypertension and average/below-average cholesterol concentrations, but without established coronary disease.

UR - https://www.scopus.com/pages/publications/20944448451

M3 - Journal article

C2 - 15855581

SN - 0149-5992

VL - 28

SP - 1151

EP - 1157

JO - Diabetes Care

JF - Diabetes Care

IS - 5

ER -

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)

Abstract

Other files and links

Fingerprint

Cite this